RNA
Atrium Therapeutics, Inc.
7.80$
-3.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Atrium Therapeutics, Inc. (RNA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -3.9 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -37 | 17 | -70 | -65 | -66 | -100 | -125 | -200 | -156 | -19 | -31 | -3.9 | -210 | |
| 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 | -7.8 | 1.1 | 0.1 | 0.2 | 0.3 | 1.7 | |
| 9.8 | 9.8 | 10 | 13 | 14 | 14 | 18 | 18 | 19 | 3.6 | 12 | 0.9 | 36 | |
| 7.4 | 69 | -10 | -4.1 | 6.0 | -6.2 | -23 | -58 | -0.5 | 5.8 | -28 | 15 | -8.0 | |
| 0.9 | 0.9 | 0.9 | 0.5 | 1.7 | 3.9 | 3.8 | 3.3 | 3.9 | 0.9 | 2.1 | 0.0 | 6.9 | |
| -31 | 51 | -33 | -275 | -482 | -64 | 157 | 185 | -588 | -0.9 | -2.1 | -192 | -782 | |
| 0.0 | 32 | 389 | 447 | 342 | 14 | 1.9 | 3.8 | 850 | 20 | 302 | 0.0 | 1,172 | |
| -68 | 99 | 286 | 107 | -206 | -150 | 34 | -10 | 106 | 32 | 268 | -195 | 211 | |
| -38 | 16 | -71 | -66 | -67 | -104 | -129 | -203 | -160 | -20 | -33 | -4.0 | -217 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.